📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Amira Pharmaceuticals

1.1 - Company Overview

Amira Pharmaceuticals Logo

Amira Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small-molecule pharmaceutical research focused on the discovery and early development of new drugs to treat inflammatory disease, leveraging unparalleled insights into bioactive lipid pathways and complex signaling processes controlling conditions including asthma.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Amira Pharmaceuticals

One Lambda Logo

One Lambda

HQ: United States Website
  • Description: Provider of histocompatibility (HLA) typing tests using serological and molecular technologies, and manufacturer of antibody detection products, laboratory instrumentation, and computer software used to simplify and automate testing procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full One Lambda company profile →
TxCell Logo

TxCell

HQ: France Website
  • Description: Provider of cell-based immuno-therapies for severe chronic inflammatory diseases with high medical need, using unique proprietary technology; a spin-off of Inserm based in Sophia Antipolis near Nice, France.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TxCell company profile →
Cyxone Logo

Cyxone

HQ: Sweden Website
  • Description: Provider of biopharmaceutical R&D focused on cyclotide-based drugs for severe autoimmune diseases. Operates via an international expert network across research, development and manufacturing. Pipeline includes Rabeximod, an oral Phase 2 candidate for rheumatoid arthritis targeting inflammatory macrophages, and T20K, an early clinical candidate for multiple sclerosis modulating T cell activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cyxone company profile →
BioAtla Logo

BioAtla

HQ: United States Website
  • Description: Provider of conditionally active biologics (CABs) for cancer-targeted therapeutics activated under specific physiological conditions; the CIAO! platform for antibody optimization; CAB-ADCs, CAB-CAR-T, and CAB-Bispecifics to improve safety and efficacy; and Mecbotamab Vedotin, a CAB-AXL-ADC for AXL-expressing tumors evaluated in sarcoma and NSCLC.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioAtla company profile →
Anokion Logo

Anokion

HQ: Switzerland Website
  • Description: Provider of antigen-specific immune tolerance solutions, including an engineered-protein platform for targeted autoimmune therapy without broad immunosuppression; liver-targeting technology to modulate inflammatory responses in antigen-mediated autoimmune diseases; antigen-specific vaccines to prevent reactions to self-antigens; and clinical research services to develop and test new therapies, reducing therapeutic protein immunogenicity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Anokion company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Amira Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Amira Pharmaceuticals

2.2 - Growth funds investing in similar companies to Amira Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Amira Pharmaceuticals

4.2 - Public trading comparable groups for Amira Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Amira Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Amira Pharmaceuticals

What does Amira Pharmaceuticals do?

Amira Pharmaceuticals is a provider of small-molecule pharmaceutical research focused on the discovery and early development of new drugs to treat inflammatory disease, leveraging unparalleled insights into bioactive lipid pathways and complex signaling processes controlling conditions including asthma.

Who are Amira Pharmaceuticals's competitors?

Amira Pharmaceuticals's competitors and similar companies include One Lambda, TxCell, Cyxone, BioAtla, and Anokion.

Where is Amira Pharmaceuticals headquartered?

Amira Pharmaceuticals is headquartered in United States.

How many employees does Amira Pharmaceuticals have?

Amira Pharmaceuticals has 1,000 employees 🔒.

When was Amira Pharmaceuticals founded?

Amira Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Amira Pharmaceuticals in?

Amira Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Amira Pharmaceuticals

Who are the top strategic acquirers in Amira Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Amira Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Amira Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Amira Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Amira Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Amira Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Amira Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Amira Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Amira Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Amira Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Amira Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Amira Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Amira Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Amira Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Amira Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Amira Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Amira Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Amira Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Amira Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Amira Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Amira Pharmaceuticals